Literature DB >> 20351271

Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species.

Sawako Suzuki1, Tomoaki Tanaka, Masha V Poyurovsky, Hidekazu Nagano, Takafumi Mayama, Shuichi Ohkubo, Maria Lokshin, Hiroyuki Hosokawa, Toshinori Nakayama, Yutaka Suzuki, Sumio Sugano, Eiichi Sato, Toshitaka Nagao, Koutaro Yokote, Ichiro Tatsuno, Carol Prives.   

Abstract

We identified a p53 target gene, phosphate-activated mitochondrial glutaminase (GLS2), a key enzyme in conversion of glutamine to glutamate, and thereby a regulator of glutathione (GSH) synthesis and energy production. GLS2 expression is induced in response to DNA damage or oxidative stress in a p53-dependent manner, and p53 associates with the GLS2 promoter. Elevated GLS2 facilitates glutamine metabolism and lowers intracellular reactive oxygen species (ROS) levels, resulting in an overall decrease in DNA oxidation as determined by measurement of 8-OH-dG content in both normal and stressed cells. Further, siRNA down-regulation of either GLS2 or p53 compromises the GSH-dependent antioxidant system and increases intracellular ROS levels. High ROS levels following GLS2 knockdown also coincide with stimulation of p53-induced cell death. We propose that GLS2 control of intracellular ROS levels and the apoptotic response facilitates the ability of p53 to protect cells from accumulation of genomic damage and allows cells to survive after mild and repairable genotoxic stress. Indeed, overexpression of GLS2 reduces the growth of tumor cells and colony formation. Further, compared with normal tissue, GLS2 expression is reduced in liver tumors. Thus, our results provide evidence for a unique metabolic role for p53, linking glutamine metabolism, energy, and ROS homeostasis, which may contribute to p53 tumor suppressor function.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20351271      PMCID: PMC2867754          DOI: 10.1073/pnas.1002459107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  Molecular cloning, sequencing and expression studies of the human breast cancer cell glutaminase.

Authors:  P M Gómez-Fabre; J C Aledo; A Del Castillo-Olivares; F J Alonso; I Núñez De Castro; J A Campos; J Márquez
Journal:  Biochem J       Date:  2000-01-15       Impact factor: 3.857

2.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

3.  Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells.

Authors:  L J Reitzer; B M Wice; D Kennell
Journal:  J Biol Chem       Date:  1979-04-25       Impact factor: 5.157

4.  The antioxidant function of the p53 tumor suppressor.

Authors:  Anna A Sablina; Andrei V Budanov; Galina V Ilyinskaya; Larissa S Agapova; Julia E Kravchenko; Peter M Chumakov
Journal:  Nat Med       Date:  2005-11-13       Impact factor: 53.440

5.  c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism.

Authors:  Ping Gao; Irina Tchernyshyov; Tsung-Cheng Chang; Yun-Sil Lee; Kayoko Kita; Takafumi Ochi; Karen I Zeller; Angelo M De Marzo; Jennifer E Van Eyk; Joshua T Mendell; Chi V Dang
Journal:  Nature       Date:  2009-02-15       Impact factor: 49.962

6.  Mutation of RRM2B, encoding p53-controlled ribonucleotide reductase (p53R2), causes severe mitochondrial DNA depletion.

Authors:  Alice Bourdon; Limor Minai; Valérie Serre; Jean-Philippe Jais; Emmanuelle Sarzi; Sophie Aubert; Dominique Chrétien; Pascale de Lonlay; Véronique Paquis-Flucklinger; Hirofumi Arakawa; Yusuke Nakamura; Arnold Munnich; Agnès Rötig
Journal:  Nat Genet       Date:  2007-05-07       Impact factor: 38.330

Review 7.  p53: new roles in metabolism.

Authors:  Karim Bensaad; Karen H Vousden
Journal:  Trends Cell Biol       Date:  2007-05-03       Impact factor: 20.808

8.  Novel form of phosphate activated glutaminase in cultured astrocytes and human neuroblastoma cells, PAG in brain pathology and localization in the mitochondria.

Authors:  E Kvamme; L S H Nissen-Meyer; B A Roberg; I Aa Torgner
Journal:  Neurochem Res       Date:  2008-02-15       Impact factor: 3.996

9.  The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression.

Authors:  Fabiana Schwartzenberg-Bar-Yoseph; Michal Armoni; Eddy Karnieli
Journal:  Cancer Res       Date:  2004-04-01       Impact factor: 12.701

10.  Identification of ALDH4 as a p53-inducible gene and its protective role in cellular stresses.

Authors:  Kyong-Ah Yoon; Yusuke Nakamura; Hirofumi Arakawa
Journal:  J Hum Genet       Date:  2004-02-25       Impact factor: 3.172

View more
  289 in total

1.  Golgi N-glycan branching N-acetylglucosaminyltransferases I, V and VI promote nutrient uptake and metabolism.

Authors:  Anas M Abdel Rahman; Michael Ryczko; Miyako Nakano; Judy Pawling; Tania Rodrigues; Anita Johswich; Naoyuki Taniguchi; James W Dennis
Journal:  Glycobiology       Date:  2014-10-01       Impact factor: 4.313

2.  Parkin, a p53 target gene, mediates the role of p53 in glucose metabolism and the Warburg effect.

Authors:  Cen Zhang; Meihua Lin; Rui Wu; Xiaowen Wang; Bo Yang; Arnold J Levine; Wenwei Hu; Zhaohui Feng
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-19       Impact factor: 11.205

Review 3.  p53 and metabolism: old player in a new game.

Authors:  Nirmalya Sen; Yatendra Kumar Satija; Sanjeev Das
Journal:  Transcription       Date:  2012 May-Jun

4.  Journal club. A cancer biologist weighs up p53, metabolism and cancer.

Authors:  Gerry Melino
Journal:  Nature       Date:  2010-08-19       Impact factor: 49.962

5.  Alternative fuel--another role for p53 in the regulation of metabolism.

Authors:  Karen H Vousden
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-14       Impact factor: 11.205

Review 6.  The engine driving the ship: metabolic steering of cell proliferation and death.

Authors:  Marisa R Buchakjian; Sally Kornbluth
Journal:  Nat Rev Mol Cell Biol       Date:  2010-10       Impact factor: 94.444

Review 7.  Alterations of metabolic genes and metabolites in cancer.

Authors:  Eric K Oermann; Jing Wu; Kun-Liang Guan; Yue Xiong
Journal:  Semin Cell Dev Biol       Date:  2012-01-28       Impact factor: 7.727

Review 8.  Modulation of oxidative stress as an anticancer strategy.

Authors:  Chiara Gorrini; Isaac S Harris; Tak W Mak
Journal:  Nat Rev Drug Discov       Date:  2013-12       Impact factor: 84.694

Review 9.  The molecular rationale for therapeutic targeting of glutamine metabolism in pulmonary hypertension.

Authors:  Thomas Bertero; Dror Perk; Stephen Y Chan
Journal:  Expert Opin Ther Targets       Date:  2019-05-11       Impact factor: 6.902

Review 10.  Therapeutic strategies impacting cancer cell glutamine metabolism.

Authors:  Michael J Lukey; Kristin F Wilson; Richard A Cerione
Journal:  Future Med Chem       Date:  2013-09       Impact factor: 3.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.